Pharmacology of Endocrine, Cardiovascular, and Renal Systems

When treating DKA, nurses must follow a specific sequence: potassium replacement must often be addressed before or alongside the initiation of insulin, as insulin causes potassium to shift from the blood into the cells, potentially causing dangerous hypokalemia.

Monitoring and Complications

To monitor diabetes, clinicians use two primary metrics:

1. Fasting Blood Sugar: Reflects the immediate glucose level at a single point in time.
2. A1C: Reflects the average glycemic control over the previous 2–3 months.

Exam Tip: Hypoglycemia Awareness Patients must be educated to recognize hypoglycemia (shaking, sweating, confusion). Be aware that beta blockers can mask the sympathetic symptoms of hypoglycemia (like tachycardia), making it harder for the patient to realize their blood sugar is dropping.

Metabolic Syndrome is a cluster of risk factors (including hypertension, hyperglycemia, and dyslipidemia) that significantly increases the risk of cardiovascular disease and Type II diabetes.

Cardiovascular Medications

Antihypertensives and Ventricular Remodeling

ACE Inhibitors are a cornerstone of blood pressure management. A critical clinical use for ACE inhibitors is in patients who have suffered a Myocardial Infarction (MI); they help prevent ventricular remodeling, which is the unwanted structural change and enlargement of the heart muscle that leads to heart failure. However, ACE inhibitors can cause angioedema (severe swelling of the face/airways) and are contraindicated in certain populations, such as pregnant women.

Antianginals

Angina is chest pain caused by reduced blood flow to the heart. Different drug classes target different mechanisms:

• Nitrates: Used for acute relief of angina.
• Beta Blockers: These reduce the heart's workload. They can be cardioselective (targeting only beta-1 receptors in the heart) or non-cardioselective (affecting beta-1 and beta-2 receptors in the lungs and elsewhere).
• Calcium Channel Blockers: Used for stable angina and specifically for Prinzmetal’s angina (vasospastic angina).

Antilipidemics

Managing cholesterol involves balancing lipoproteins. Low-density lipoprotein (LDL) is "bad" cholesterol, while High-density lipoprotein (HDL) is "good" cholesterol.

• Statins: The first-line therapy for high cholesterol. They should typically be administered at night.
• Niacin and Fibrates: Used to manage specific lipid profiles, though Niacin can cause side effects like flushing.

Renal and Diuretic Therapy

Diuretics are used to reduce fluid volume, but they must be managed carefully due to their impact on electrolytes.

1. Loop Diuretics (e.g., Furosemide): These are the "most potent" diuretics and are used when rapid diuresis is required, such as in acute pulmonary edema.
2. Thiazide Diuretics (e.g., Hydrochlorothiazide): Commonly used for long-term maintenance of hypertension. They may be particularly beneficial for perimenopausal women.
3. Aldosterone-blocking Diuretics (e.g., Spironolactone): These are "potassium-sparing" and require close monitoring of potassium levels to avoid hyperkalemia.
4. Mannitol: An osmotic diuretic used primarily to reduce intracranial pressure.

Critical Lab Monitoring For all diuretic therapies, the nurse must monitor electrolyte levels (especially Potassium) and renal function (BUN/Creatinine) to prevent life-threatening imbalances.

---

Summary Table of Key Medications